Product Images Simvastatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Simvastatin NDC 63629-1199 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Footnote for Table 3 - Footnote for Table 3
The text provides information on the results of chemical assays with various inhibitors of the CYP3A4 enzyme, including ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone, in conjunction with simvastatin acid. It also notes that the effect of grapefruit juice on simvastatin pharmacokinetics is not well studied, but provides details on two studies involving administration of grapefruit juice with simvastatin. The first involved three days of administration of single-strength grapefruit juice in the morning along with simvastatin on the third evening. The second involved two days of administration of double-strength grapefruit juice, followed by administration of simvastatin with 200 mL of grapefruit juice at various intervals.*
Label - lbl636291199
This is a description of a medication called NILD that comes in the form of tablets. Each tablet contains 40mg of Simvastatin, USP and should be kept out of reach of children. It is recommended to store this medication in a room temperature of 20° to 25°C (68° to 77°F). The medication should be dispensed in a light-resistant container with a child-resistant closure. The medication comes with a label that reads: NDC 63629-1199-1 and BRP Rx only.*
Figure 9 - simvastatin 10
table2 - simvastatin 2
The text is a table showing adverse reactions reported in patients treated with Simvastatin compared to placebo. The table displays the percentage of patients experiencing adverse reactions grouped by body system, and the percentage of patients with each reaction is listed in the corresponding column. Adverse reactions that were reported in greater than 2% of patients treated with Simvastatin and greater than placebo in 45 patients are shown. Some of the adverse reactions listed include edema/swelling, abdominal pain, atrial fibrillation, constipation, myalgia, headache, insomnia, bronchitis, and eczema.*
Structure - simvastatin 3
table 3 - simvastatin 4
table 4 - simvastatin 5
Figure 5 - simvastatin 6
This text seems to be displaying the results of a study on the use of Simvastatin in preventing major vascular events and coronary events. The study involved around 20,858 patients with or without cHD, peripheral vascular disease, or coxae vascular disease. The text presents data on the incidence of major coronary events in patients taking Simvastatin versus Placebo and provides a risk ratio for the drug's effectiveness. The text lacks complete sentences and context.*
Figure 6 - simvastatin 7
Figure 7 - simvastatin 8
The text is not readable as it seems to contain mostly symbols and some unclear errors.*
Figure 8 - simvastatin 9
table 1 - table1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.